D. Illingworth

发表

National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

J. Mckenney, M. Proschan, S. Grundy, 2002 .

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

J. Mckenney, S. Grundy, R. Cooper, 2001, JAMA.

Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans.

P. Cryer, A. Avogaro, D. Illingworth, 1992, The American journal of physiology.

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Daniel Steinberg, D. Roger Illingworth, Gustav Schonfeld, 1988, Archives of internal medicine.

Lipoproteins in Health and Diseases

D. Illingworth, J. Shepherd, J. Betteridge, 1999 .

Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function.

P. Corey, D. Illingworth, C. Mehling, 2001, Metabolism: clinical and experimental.

Drug therapy for hyperlipidemia.

D. Illingworth, J. S. Prihoda, 1992, American pharmacy.

Cholesteryl ester hydrolase activity in mononuclear cells from patients with type II hypercholesterolemia.

D. Illingworth, F. Yatsu, F. Hagemenas, 1984, Atherosclerosis.

Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia.

D. Illingworth, N. Yahagi, R. Nagai, 2000, Journal of lipid research.

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, J. P. O'Malley, J. O'Malley, 1990, Metabolism: clinical and experimental.

Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis

D. Illingworth, P. J. Jones, A. Pappu, 1992, European journal of clinical investigation.

Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys.

D. Illingworth, P. Sarrel, R. Mishra, 2005, The Journal of clinical endocrinology and metabolism.

Lipid-Lowering Drugs

D. Illingworth, Dr D. Roger Illingworth, 1987, Drugs.

Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.

D. Illingworth, S. Bacon, Sandra R. Bacon, 1989, Arteriosclerosis.

Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, S. Bacon, 1989, Circulation.

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.

D. Illingworth, S. Bacon, 1987, The American journal of cardiology.

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.

R. Lees, D. Hunninghake, D. Illingworth, 1987, Annals of internal medicine.

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.

D. Illingworth, J. Hosenpud, D. Norman, 1988, The New England journal of medicine.

Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.

D. Illingworth, P. Patton, K. Burry, 1989, American journal of obstetrics and gynecology.

Exchange of phospholipids between low and high density lipoproteins of squirrel monkeys.

D. Illingworth, O. Portman, 1972, Journal of lipid research.

Independence of phospholipid and protein exchange between plasma lipoproteins in vivo and in vitro.

D. Illingworth, O. Portman, 1972, Biochimica et biophysica acta.

New risk factors for coronary heart disease.

D. Illingworth, 1999, The American journal of medicine.

The Influence of Dietary n‐3 Fatty Acids on Plasma Lipids and Lipoproteins a

D. Illingworth, E. Schmidt, 1993, Annals of the New York Academy of Sciences.

The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia.

R. de Caterina, D. Illingworth, S. Kristensen, 1993, Atherosclerosis.

Fish consumption and mortality from coronary heart disease.

Ivar Heuch, S. Vollset, D. Reed, 1985, The New England journal of medicine.

Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.

W. Harris, D. Illingworth, S. Goodnight, 1982, Arteriosclerosis.

Present Status of Polyunsaturated Fats in the Prevention of Cardiovascular Disease

D. Illingworth, W. Connor, 1980 .

An Overview of Lipid-Lowering Drugs

D. Illingworth, 2012, Drugs.

Clinical Implications of New Drugs for Lowering Plasma Cholesterol Concentrations

D. Illingworth, 1991, Drugs.

Management of hypercholesterolemia.

D. Illingworth, 2001, The Medical clinics of North America.

Management of hypercholesterolemia.

D. Illingworth, D. Illingworth, 2001, The Medical clinics of North America.

Adverse ocular effects associated with niacin therapy.

Frederick W. Fraunfelder, D. Illingworth, F. Fraunfelder, 1995, The British journal of ophthalmology.

Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia.

D. Illingworth, J. P. O'Malley, M. L. Larsen, 1994, Atherosclerosis.

Drug treatment of dyslipoproteinemia.

D. Illingworth, M. L. Larsen, M. Larsen, 1994, The Medical clinics of North America.

Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.

R. Mahley, D. Illingworth, K. Weisgraber, 1993, Atherosclerosis.

How effective is drug therapy in heterozygous familial hypercholesterolemia?

D. Illingworth, 1993, The American journal of cardiology.

Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin

D. Illingworth, D. Erkelens, M. Tikkanen, 1994, The Lancet.

Carcinogenicity of lipid-lowering drugs.

D. Illingworth, 1996, JAMA.

Effects of Colesevelam HCl on Sterol and Bile Acid Excretion in Patients with Type IIa Hypercholesterolemia

D. Illingworth, K. Setchell, J. Isaacsohn, 2005, Digestive Diseases and Sciences.

Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids.

W. Harris, D. Illingworth, W. Connor, 1988, Journal of lipid research.

Plasma lipids and hypertension: response to calcium supplementation.

D. Illingworth, N. Karanja, D. McCarron, 1987, The American journal of clinical nutrition.

Carcinogenicity of lipid-lowering drugs.

D. Illingworth, 1996, JAMA.

Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.

W. Harris, D. Illingworth, W. Connor, 1986, The New England journal of medicine.

The potential role of antioxidants in the prevention of atherosclerosis.

D. Illingworth, 1993, Journal of nutritional science and vitaminology.

PLASMA MEVALONATE RESPONSE IN LOVASTATIN-RELATED MYOPATHY

D. Illingworth, A. Pappu, G. Thompson, 1989, The Lancet.

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

D. Illingworth, E. Schmidt, 1994 .

Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.

A. Gotto, S. Kelsey, D. Illingworth, 1992, The American journal of cardiology.

Adrenal cortical function in homozygous familial hypercholesterolemia.

R. Lees, D. Illingworth, A. M. Lees, 1983, Metabolism: clinical and experimental.

Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, A. Pappu, 1989, The Journal of laboratory and clinical medicine.

Neutral lipid transfer activities in the plasma of patients with abetalipoproteinemia.

D. Illingworth, A. Pappu, Anuradha S. Pappu, 1988, Atherosclerosis.

Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, A. Pappu, G. Sexton, 1992, Atherosclerosis.

Metabolism of lipoproteins in nonhuman primates. Reduced secretion of very low density lipoproteins in squirrel monkeys with diet-induced hypercholesterolemia.

D. Illingworth, O. Portman, L. E. Whipple, 1975, Atherosclerosis.

Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases.

D. Illingworth, W. Connor, S. Inkeles, 1986, The American journal of medicine.

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, G. Sexton, 1984, The Journal of clinical investigation.

The effects of hyperlipidemia on lipoprotein metabolism in squirrel monkeys and rabbits.

D. Illingworth, O. Portman, M. Alexander, 1975, Biochimica et biophysica acta.

Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein B.

S. Grundy, G. Vega, D. Illingworth, 1983, Metabolism: clinical and experimental.

Metabolism of lipoproteins in nonhuman primates. Studies on the origin of low density lipoprotein apoprotein in the plasma of the squirrel monkey.

D. Illingworth, 1975, Biochimica et biophysica acta.

Metabolic interrelationships between the lipids of very low, low and high density lipoproteins in the squirrel monkey

D. Illingworth, O. Portman, L. E. Whipple, 1974 .

Diurnal variations in the plasma concentrations of mevalonic acid in patients with abetalipoproteinaemia

D. Illingworth, A. Pappu, Anuradha S. Pappu, 1994, European journal of clinical investigation.

Arterial metabolism in primates.

D. Illingworth, O. Portman, 1976, Primates in medicine.

Reduction of Plasma Lipids and Lipoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia

W. Harris, D. Illingworth, W. Connor, 1987 .

Triglyceride-lowering agents: fibrates and nicotinic acid

D. Illingworth, M. L. Larsen, 1993 .

Lymphadenopathy associated with severe hypertriglyceridemia.

D. Illingworth, D. Leaf, W. Connor, 1990, JAMA.

The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, A. Pappu, 2002, Atherosclerosis.

FAMILIAL HYPERCHOLESTEROLAEMIA AND PRIMARY HYPOTHYROIDISM: COEXISTENCE OF BOTH DISORDERS IN A YOUNG WOMAN WITH SEVERE HYPERCHOLESTEROLAEMIA

D. Illingworth, M. McClung, W. Connor, 1981, Clinical endocrinology.

Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, A. Pappu, S. Bacon, 1989, Metabolism: clinical and experimental.

The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia

D. Illingworth, F. Hagemenas, A. Pappu, 1990, European journal of clinical investigation.

Cholesterol Homeostasis in Mononuclear Leukocytes from Patients with Familial Hypercholesterolemia Treated with Lovastatin

D. Illingworth, F. Hagemenas, 1989, Arteriosclerosis.

Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia

D. Illingworth, 1986, Clinical pharmacology and therapeutics.

Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia.

D. Illingworth, S. Lindsey, N. Alam, 1984, The Journal of clinical endocrinology and metabolism.

Abetalipoproteinemia. Report of two cases and review of therapy.

D. Illingworth, R. Miller, W. Connor, 1980, Archives of neurology.

HMG-CoA Reductase Inhibitors

D. Illingworth, J. Tobert, Bruinvels Infarm Sweelincklaan, 2002, Milestones in Drug Therapy MDT.

The influence of plasma lipoproteins from patients with abetalipoproteinemia on cellular cholesterol esterification.

D. Illingworth, F. Hagemenas, 1987, Atherosclerosis.

Rotation in [ C II ]-emitting gas detected in two galaxies in the Epoch of Reionization

R. Bouwens, L. Bradley, Wei Zheng, 2018 .

Regulation of cholesterol synthesis by plasma lipoproteins from patients with abetalipoproteinemia.

D. Illingworth, E. Sundberg, N. Alam, 1983, Atherosclerosis.

Lipid metabolism in abetalipoproteinemia: a study of cholesterol absorption and sterol balance in two patients.

D. S. Lin, D. Illingworth, J. Diliberti, 1980, Gastroenterology.

Sterol balance in abetalipoproteinemia: studies in a patient with homozygous familial hypobetalipoproteinemia.

D. Illingworth, W. Connor, N. Buist, 1979, Metabolism: clinical and experimental.

Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.

D. Illingworth, A. Pappu, S. Bacon, 2003, The Journal of laboratory and clinical medicine.

Increased urinary mevalonic acid excretion in patients with abetalipoproteinemia and homozygous hypobetalipoproteinemia.

R. Gregg, D. Illingworth, A. Pappu, 1989, Atherosclerosis.

THE COMPOSITION OF LIPIDS IN CEREBROSPINAL FLUID OF CHILDREN AND ADULTS

D. Illingworth, J. Glover, D. R. Illingworth, 1971, Journal of neurochemistry.

The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia.

D. Illingworth, A. Pappu, J. S. Prihoda, 1991, The Journal of clinical endocrinology and metabolism.

Impact of increasing calcium in the diet on nutrient consumption, plasma lipids, and lipoproteins in humans.

D. Illingworth, N. Karanja, D. McCarron, 1994, The American journal of clinical nutrition.

Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia.

D. Illingworth, N. Alam, S. S. Alam, 1983, Metabolism: clinical and experimental.

Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system

A. Gotto, S. Kelsey, D. Illingworth, 1998 .

Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion DOI 10.1194/jlr.M200163-JLR200

D. S. Lin, D. Illingworth, R. Steiner, 2002, Journal of Lipid Research.

Lecithin: cholesterol acyl transferase activity in human cerebrospinal fluid.

D. Illingworth, J. Glover, 1970, Biochimica et biophysica acta.

Lysolecithin binding to human and squirrel monkey plasma and tissue components.

D. Illingworth, O. Portman, 1973, Biochimica et biophysica acta.

Regression of Tendon Xanthomas in Patients With Familial Hypercholesterolemia Treated With Lovastatin

D. Illingworth, R. Cope, S. Bacon, 1990, Southern medical journal.

NF1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression

D. Illingworth, M. Axthelm, R. Mishra, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Economics of lipid lowering with HMG CoA reductase inhibitors: To the editor

D. Illingworth, D. Roger Illingworth, 1995 .

Factors determining the concentrations of lysolecithin in plasma and tissues.

D. Illingworth, O. Portman, 1974, Scandinavian journal of clinical and laboratory investigation. Supplementum.

The apolipoprotein B Q3405E polymorphism has no effect on its low-density-lipoprotein receptor binding affinity

D. Illingworth, C. Pullinger, J. Kane, 1996, Human Genetics.

SIMULTANEOUS INCORPORATION OF ORALLY ADMINISTERED [9, 10‐3H2]OLEIC AND [1‐14C]LINOLEIC ACIDS INTO LIPIDS OF THE ADULT RAT BRAIN

D. Illingworth, J. Glover, D. R. Illingworth, 1973, Journal of neurochemistry.

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia.

D. Illingworth, J. P. O'Malley, J. O'Malley, 1990, Metabolism: clinical and experimental.

LYSOLECITHIN AND SPHINGOSINEPHOSPHORYL‐CHOLINE IN THE METABOLISM OF BRAIN PHOSPHOLIPIDS OF THE RHESUS MONKEY (MACAC A MULATTA): EFFECTS OF DEVELOPMENT

D. Illingworth, O. Portman, M. Alexander, 1973, Journal of neurochemistry.

Peripheral relaxin levels during pregnancy in a woman with homozygous familial hypobetalipoproteinemia.

D. Illingworth, B. Carr, L. Goldsmith, 1988, Fertility and sterility.

The influence of dietary fats on lipid synthesis by human mononuclear cells.

D. Illingworth, E. Sundberg, 1981, Biochemical Society transactions.

A review of clinical trials comparing HMG-CoA reductase inhibitors.

D. Illingworth, J. Tobert, 1994, Clinical therapeutics.

Effect of growth hormone replacement on development of hypothyroidism and hyperlipidemia.

D. Illingworth, C. Hanna, S. Lafranchi, 1985, The Journal of pediatrics.

Effects of Saturated and Polyunsaturated Fatty Acids on Plasma Lipids, Platelets and the Vascular System

D. Illingworth, S. Goodnight, W. Connor, 1987 .

Comparative effects of lovastatin and niacin in primary hypercholesterolemia

D. Illingworth, E. Stein, R. Zupkis, 1994 .

Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100

R. Mahley, D. Illingworth, K. Weisgraber, 1992, The Lancet.

Apolipoprotein ∈4 and coronary artery disease

D. Illingworth, L. Havekes, K. Lie, 1992, The Lancet.

Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol Published, JLR Papers in Press, September 18, 2006.

D. Illingworth, R. Steiner, Julia M Jordan, 2006, Journal of Lipid Research.

Endocrine changes during pregnancy in a patient with homozygous familial hypobetalipoproteinemia.

D. Illingworth, B. Carr, C. Parker, 1986, The New England journal of medicine.

Adrenal function in heterozygous and homozygous hypobetalipoproteinemia.

D. Illingworth, E. Orwoll, T. A. Kenny, 1982, The Journal of clinical endocrinology and metabolism.

Dietary cholesterol feeding suppresses human cholesterol synthesis measured by deuterium incorporation and urinary mevalonic acid levels.

D. Illingworth, P. J. Jones, A. Pappu, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Hypolipidaemic effects of n‐3 fatty acids in primary hyperlipoproteinaemia

W. Harris, D. Illingworth, W. Connor, 1989, Journal of internal medicine. Supplement.

Impaired cortisol secretion in abetalipoproteinemia.

D. Illingworth, E. Orwoll, W. Connor, 1980, The Journal of clinical endocrinology and metabolism.

Effects of Omega-3 Fatty Acids on Risk Factors for Cardiovascular Disease

D. Illingworth, D. Ullmann, 2020 .

Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.

D. Illingworth, E. Sundberg, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100.

S. R. Thatcher, R. Mahley, D. Illingworth, 1993, Metabolism: clinical and experimental.

The neuropathy of abetalipoproteinemia

D. Illingworth, W. Bradley, R. Miller, 1980, Neurology.

The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia.

D. Illingworth, D. Corbin, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH.

D. Illingworth, E. Orwoll, W. Connor, 1982, The Journal of laboratory and clinical medicine.

Lipid composition and lipolytic activities in milk from a patient with homozygous familial hypobetalipoproteinemia.

D. Illingworth, C. S. Wang, 1987, The American journal of clinical nutrition.

An improved method for separating the products of lecithin and lysolecithin catabolism.

D. Illingworth, O. Portman, 1972, Journal of chromatography.

Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall.

D. Illingworth, O. Portman, 1974, Biochimica et biophysica acta.

Phospholipases in cerebrospinal fluid and cell fractions of human brain.

D. Illingworth, J. Glover, 1969, The Biochemical journal.

Changes in brain and sciatic nerve composition with development of the rhesus monkey (Macaca mulatta).

D. Illingworth, O. Portman, M. Alexander, 1972, Brain research.

Effects of saturated, monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans.

D. Illingworth, N. Becker, W. Connor, 1983, The American journal of clinical nutrition.

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia.

D. Illingworth, F. Raal, A. Marais, 2000, Atherosclerosis.

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia.

D. Illingworth, F. Raal, E. Stein, 1997, Atherosclerosis.

Changes in cerebroside synthetic activities of the brain with development of the rhesus monkey (Macaca mulatta).

D. Illingworth, O. Portman, M. Alexander, 1973, Brain research.

The uptake and metabolism of plasma lysophosphatidylcholine in vivo by the brain of squirrel monkeys.

D. Illingworth, O. Portman, 1972, The Biochemical journal.

The exchange of phospholipids between plasma lipoproteins and rapidly dividing human cells grown in tissue culture.

D. Illingworth, A. Robertson, O. Portman, 1973, Biochimica et biophysica acta.

Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.

W. Harris, D. Illingworth, W. Connor, 1984, Arteriosclerosis.

Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial

D. Hunninghake, D. Illingworth, R. Goldberg, 1996, Journal of cardiovascular pharmacology and therapeutics.

Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia

W. Harris, D. Illingworth, W. Connor, 1985 .

Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.

D R Illingworth, D. Illingworth, 1984, Annals of internal medicine.

Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia.

D. Illingworth, S. Goodnight, W. Connor, 1990, Haemostasis.

The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study.

D. Illingworth, D. Leaf, W. Connor, 1989, JAMA.

Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria.

D. Illingworth, W. Bennett, T. Golper, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ciprofibrate in the therapy of type II hypercholesterolemia. A double-blind trial.

D. Illingworth, W. Connor, G. Sexton, 1982, Atherosclerosis.

Community cholesterol screening: medical follow-up in subjects identified with high plasma cholesterol levels.

D. Illingworth, M. Malinow, C. Morris, 1990, Preventive medicine.

Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.

D. Illingworth, E. Stein, R. Zupkis, 1994, Archives of internal medicine.

Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.

D. Illingworth, M. Cheung, A. C. Wolf, 1992, Biochimica et biophysica acta.

Indications for low-density lipoprotein apheresis.

D. Illingworth, E. Stein, B. Gordon, 1994, The American journal of cardiology.

Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia.

W. Harris, D. Illingworth, W. Connor, 1984, Metabolism: clinical and experimental.

Lipid-lowering drug therapy: more knowledge leads to more problems for composers of guidelines

D. Illingworth, P. Durrington, 2000, Current opinion in lipidology.

Achievement of low-density lipoprotein cholesterol goals: new strategies to address new guidelines.

D. Illingworth, D. Illingworth, 2003, Cardiology clinics.

Niacin maculopathy.

M. Klein, D. Illingworth, R. Millay, 1988, Ophthalmology.

Treatment of Hyperlipidemia in Specific Types of Patients: The Elderly, Women, and Patients with Coronary Artery Disease

D. Illingworth, 1995 .

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

D. Illingworth, H. Ginsberg, Henry N. Ginsberg, 2001, The American journal of cardiology.

Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia.

D. Illingworth, C. Maslen, J. P. O'Malley, 1998, Circulation.

The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day.

D R Illingworth, D. Hunninghake, D. Illingworth, 1997, The American journal of cardiology.

A Randomized Multicenter Trial Comparing the Efficacy of Simvastatin and Fluvastatin

D. Hunninghake, D. Illingworth, E. Stein, 1996, Journal of cardiovascular pharmacology and therapeutics.

Effects of fish oil on VLDL triglyceride kinetics in humans.

W. Harris, D. Illingworth, D. Foster, 1990, Journal of lipid research.

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.

P. Hopkins, D. Illingworth, M. Siimes, 1999, JAMA.

A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical Trial

M. Mercuri, D. Hunninghake, D. Illingworth, 2001 .

COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA

D. Illingworth, W. Connor, B. Phillipson, 1981, The Lancet.

High density lipoprotein metabolism in a patient with abetalipoproteninemia.

D. Illingworth, W. Connor, P. Alaupovic, 1981, Annals of nutrition & metabolism.

Rhabdomyolysis after taking atorvastatin with gemfibrozil.

D. Illingworth, P. Duell, W. Connor, 1998, The American journal of cardiology.

Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia.

D. Illingworth, D. Layman, F. Hagemenas, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Triacylglycerol and very low density lipoprotein secretion into plasma of squirrel monkeys.

D. Illingworth, O. Portman, M. Alexander, 1977, Biochimica et biophysica acta.

Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

D. Illingworth, 1987, Drugs.

Expression of type III hyperlipoproteinemia in an adolescent patient with hypothyroidism.

D. Illingworth, M. Lindner, Marie A. Lindner, 1988, The Journal of pediatrics.

Lipoprotein metabolism.

D. Illingworth, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Angiotensin-converting enzyme and cardiovascular disease risk.

D. Illingworth, C. Maslen, J. O'Malley, 1999, Current opinion in lipidology.

A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.

M. Mercuri, D. Hunninghake, D. Illingworth, 2001, Current medical research and opinion.

Fish oils in hypertriglyceridemia: a dose-response study.

W. Harris, D. Illingworth, S. Goodnight, 1990, The American journal of clinical nutrition.

Hormone changes during the menstrual cycle in abetalipoproteinemia: reduced luteal phase progesterone in a patient with homozygous hypobetalipoproteinemia.

D. Illingworth, E. Keenan, E. D. Kemp, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Effects of fish oil on VLDL triglyceride kinetics in humans 1

W. Harris, D. Illingworth, D. Foster, 2002 .

EFFECT OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE III HYPERLIPOPROTEINEMIA

D. Illingworth, E. Stein, H. Ginsberg, 1996, American journal of therapeutics.

Drug therapy of hyperlipidemia.

D. Illingworth, J. S. Prihoda, 1992, Current problems in cardiology.

Management of hyperlipidemia: goals for the prevention of atherosclerosis.

D. Illingworth, 1990, Clinical and investigative medicine. Medecine clinique et experimentale.

Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease

D. Illingworth, C. Maslen, D. Babcock, 1995, Journal of Inherited Metabolic Disease.

Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.

A. Gotto, S. Kelsey, D. Illingworth, 1998, The American journal of cardiology.

Role of dietary cholesterol in the optimal diet for the treatment of hypercholesterolemia.

D. Illingworth, A. Pappu, W. Connor, 1995, The Canadian journal of cardiology.

consumption, plasma lipids, and lipoproteins in humans13

D. Illingworth, N. Karanja, D. McCarron, 1994 .

Dual hepatic metabolism of cerivastatin--clarifications.

D. Illingworth, J. Guyton, C. Dujovne, 1999, American Journal of Cardiology.

National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

J. Mckenney, M. Proschan, S. Grundy, 2015 .

Drug therapy of hypercholesterolemia.

D. Illingworth, 1988, Clinical chemistry.

Effects of long-term protein deficiency on plasma lipoprotein concentrations and metabolism in rhesus monkeys.

D. Illingworth, M. Neuringer, O. Portman, 1981, The Journal of nutrition.

Effects of Colesevelam HCl on Sterol and Bile Acid Excretion in Patients with Type IIa Hypercholesterolemia

D. Illingworth, K. Setchell, J. Isaacsohn, 2005, Digestive Diseases and Sciences.

Long term administration of lovastatin in the treatment of hypercholesterolaemia.

D. Illingworth, 1987, European heart journal.

New horizons in combination drug therapy for hypercholesterolemia.

D. Illingworth, 1989, Cardiology.

Abetalipoproteinemia: Report of Two Cases and Review of Therapy

D. Illingworth, R. Miller, W. Connor, 1980 .

Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin.

D. Illingworth, W. Connor, 1984, Annals of internal medicine.